Allovir Stock Analysis
| ALVR Stock | USD 0.45 0.01 2.17% |
Allovir is undervalued with Real Value of 5.27 and Target Price of 19.75. The main objective of Allovir stock analysis is to determine its intrinsic value, which is an estimate of what Allovir is worth, separate from its market price. There are two main types of Allovir's stock analysis: fundamental analysis and technical analysis.
The Allovir stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Allovir is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Allovir Stock trading window is adjusted to America/New York timezone.
Allovir |
Allovir Stock Analysis Notes
About 49.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.43. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allovir recorded a loss per share of 0.9. The entity had not issued any dividends in recent years. The firm had 1:10 split on the April 2, 2013. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people. For more info on Allovir please contact Diana MD at 617 433 2605 or go to https://www.allovir.com.Allovir Investment Alerts
| Allovir generated a negative expected return over the last 90 days | |
| Allovir has high historical volatility and very poor performance | |
| Allovir has some characteristics of a very speculative penny stock | |
| Allovir has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (190.42 M) with profit before overhead, payroll, taxes, and interest of 165 K. | |
| Allovir currently holds about 172.67 M in cash with (124.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Allovir has a poor financial position based on the latest SEC disclosures | |
| Roughly 49.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Allovir stock touches 52-week low at 0.47 amid market challenges - Investing.com |
Allovir Upcoming and Recent Events
| 21st of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Allovir Largest EPS Surprises
Earnings surprises can significantly impact Allovir's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-05 | 2024-06-30 | -0.1 | -0.05 | 0.05 | 50 | ||
2024-11-01 | 2024-09-30 | -0.09 | -0.0358 | 0.0542 | 60 | ||
2024-03-15 | 2023-12-31 | -0.43 | -0.36 | 0.07 | 16 |
Allovir Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Rbf Llc | 2024-09-30 | 449 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 324.7 K | Fmr Inc | 2024-09-30 | 310.6 K | D. E. Shaw & Co Lp | 2024-09-30 | 296.5 K | Two Sigma Investments Llc | 2024-09-30 | 295.2 K | State Street Corp | 2024-09-30 | 222.4 K | Commonwealth Equity Services Inc | 2024-09-30 | 201 K | Marquette Asset Management Inc. | 2024-09-30 | 178.9 K | Jane Street Group Llc | 2024-06-30 | 173 K | Ecor1 Capital, Llc | 2024-09-30 | 11.3 M | Octagon Capital Advisors Lp | 2024-09-30 | 11.2 M |
Allovir Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 85.25 M.Allovir Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.00) | (0.95) | |
| Return On Capital Employed | (1.12) | (1.17) | |
| Return On Assets | (1.00) | (0.95) | |
| Return On Equity | (1.31) | (1.24) |
Management Efficiency
Allovir has return on total asset (ROA) of (0.3653) % which means that it has lost $0.3653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8033) %, meaning that it created substantial loss on money invested by shareholders. Allovir's management efficiency ratios could be used to measure how well Allovir manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/16/2024, Return On Tangible Assets is likely to grow to -0.95. In addition to that, Return On Capital Employed is likely to drop to -1.17. At this time, Allovir's Total Assets are relatively stable compared to the past year. As of 12/16/2024, Other Current Assets is likely to grow to about 5.1 M, while Non Current Assets Total are likely to drop slightly above 3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.40 | 2.59 | |
| Tangible Book Value Per Share | 1.40 | 2.59 | |
| Enterprise Value Over EBITDA | (0.04) | (0.04) | |
| Price Book Value Ratio | 0.49 | 0.51 | |
| Enterprise Value Multiple | (0.04) | (0.04) | |
| Price Fair Value | 0.49 | 0.51 | |
| Enterprise Value | 8 M | 7.6 M |
The leadership approach at Allovir's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.741 | Return On Assets (0.37) | Return On Equity (0.80) |
Technical Drivers
As of the 16th of December 2024, Allovir shows the Mean Deviation of 3.96, standard deviation of 7.08, and Risk Adjusted Performance of (0.04). Allovir technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Allovir standard deviation and potential upside to decide if Allovir is priced correctly, providing market reflects its regular price of 0.45 per share. As Allovir is a penny stock we also strongly suggest to validate its jensen alpha numbers.Allovir Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Allovir middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Allovir. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Allovir Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Allovir insiders, such as employees or executives, is commonly permitted as long as it does not rely on Allovir's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Allovir insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Allovir Outstanding Bonds
Allovir issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Allovir uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Allovir bonds can be classified according to their maturity, which is the date when Allovir has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Allovir Predictive Daily Indicators
Allovir intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Allovir stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Allovir Forecast Models
Allovir's time-series forecasting models are one of many Allovir's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Allovir's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Allovir Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Allovir prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Allovir shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Allovir. By using and applying Allovir Stock analysis, traders can create a robust methodology for identifying Allovir entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (166.15) | (157.84) | |
| Operating Profit Margin | (186.10) | (176.79) | |
| Net Loss | (151.76) | (144.17) |
Current Allovir Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Allovir analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Allovir analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 19.75 | Hold | 1 | Odds |
Most Allovir analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Allovir stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Allovir, talking to its executives and customers, or listening to Allovir conference calls.
Allovir Stock Analysis Indicators
Allovir stock analysis indicators help investors evaluate how Allovir stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Allovir shares will generate the highest return on investment. By understating and applying Allovir stock analysis, traders can identify Allovir position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 106.9 M | |
| Common Stock Shares Outstanding | 104.1 M | |
| Total Stockholder Equity | 145.8 M | |
| Tax Provision | -415 K | |
| Property Plant And Equipment Net | 2.2 M | |
| Cash And Short Term Investments | 183.9 M | |
| Cash | 90.1 M | |
| Accounts Payable | 6.8 M | |
| Net Debt | -62.7 M | |
| 50 Day M A | 0.8051 | |
| Total Current Liabilities | 28.4 M | |
| Other Operating Expenses | 181.3 M | |
| Non Current Assets Total | 3.2 M | |
| Non Currrent Assets Other | 974 K | |
| Stock Based Compensation | 40.8 M |
Additional Tools for Allovir Stock Analysis
When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.